<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thyrotoxic <z:hpo ids='HP_0003768'>periodic paralysis</z:hpo> (<z:chebi fb="2" ids="35033,52279,9532">TPP</z:chebi>) attacks are characterized as recurrent, transient episodes of <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> that range from mild <z:mp ids='MP_0000746'>weakness</z:mp> to complete flaccid <z:hpo ids='HP_0003470'>paralysis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Episodes of <z:mp ids='MP_0000746'>weakness</z:mp> are accompanied by <z:hpo ids='HP_0002900'>hypokalemia</z:hpo>, which left untreated can lead to life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> (6) </plain></SENT>
<SENT sid="2" pm="."><plain>In this case study, we followed a patient's <z:chebi fb="120" ids="26216">potassium</z:chebi> levels analyzing how they correlate with electrocardiogram changes seen while treating his <z:hpo ids='HP_0002900'>hypokalemia</z:hpo> and ultimately his <z:hpo ids='HP_0003470'>paralysis</z:hpo> </plain></SENT>
</text></document>